S&P 500   3,329.62 (+0.39%)
DOW   29,348.10 (+0.17%)
QQQ   223.38 (+0.49%)
AAPL   318.73 (+1.11%)
FB   222.14 (+0.17%)
MSFT   167.10 (+0.56%)
GOOGL   1,479.52 (+2.02%)
AMZN   1,864.72 (-0.70%)
CGC   24.89 (+2.43%)
NVDA   249.28 (+0.14%)
BABA   227.43 (+1.56%)
MU   57.66 (-0.03%)
GE   11.81 (-0.25%)
TSLA   510.50 (-0.58%)
AMD   50.93 (+2.33%)
T   38.38 (+0.92%)
ACB   2.13 (-0.93%)
F   9.16 (-0.11%)
NFLX   339.67 (+0.31%)
PRI   128.43 (+0.05%)
BAC   34.71 (-0.03%)
GILD   62.98 (-0.35%)
DIS   144.33 (-0.54%)
S&P 500   3,329.62 (+0.39%)
DOW   29,348.10 (+0.17%)
QQQ   223.38 (+0.49%)
AAPL   318.73 (+1.11%)
FB   222.14 (+0.17%)
MSFT   167.10 (+0.56%)
GOOGL   1,479.52 (+2.02%)
AMZN   1,864.72 (-0.70%)
CGC   24.89 (+2.43%)
NVDA   249.28 (+0.14%)
BABA   227.43 (+1.56%)
MU   57.66 (-0.03%)
GE   11.81 (-0.25%)
TSLA   510.50 (-0.58%)
AMD   50.93 (+2.33%)
T   38.38 (+0.92%)
ACB   2.13 (-0.93%)
F   9.16 (-0.11%)
NFLX   339.67 (+0.31%)
PRI   128.43 (+0.05%)
BAC   34.71 (-0.03%)
GILD   62.98 (-0.35%)
DIS   144.33 (-0.54%)
S&P 500   3,329.62 (+0.39%)
DOW   29,348.10 (+0.17%)
QQQ   223.38 (+0.49%)
AAPL   318.73 (+1.11%)
FB   222.14 (+0.17%)
MSFT   167.10 (+0.56%)
GOOGL   1,479.52 (+2.02%)
AMZN   1,864.72 (-0.70%)
CGC   24.89 (+2.43%)
NVDA   249.28 (+0.14%)
BABA   227.43 (+1.56%)
MU   57.66 (-0.03%)
GE   11.81 (-0.25%)
TSLA   510.50 (-0.58%)
AMD   50.93 (+2.33%)
T   38.38 (+0.92%)
ACB   2.13 (-0.93%)
F   9.16 (-0.11%)
NFLX   339.67 (+0.31%)
PRI   128.43 (+0.05%)
BAC   34.71 (-0.03%)
GILD   62.98 (-0.35%)
DIS   144.33 (-0.54%)
S&P 500   3,329.62 (+0.39%)
DOW   29,348.10 (+0.17%)
QQQ   223.38 (+0.49%)
AAPL   318.73 (+1.11%)
FB   222.14 (+0.17%)
MSFT   167.10 (+0.56%)
GOOGL   1,479.52 (+2.02%)
AMZN   1,864.72 (-0.70%)
CGC   24.89 (+2.43%)
NVDA   249.28 (+0.14%)
BABA   227.43 (+1.56%)
MU   57.66 (-0.03%)
GE   11.81 (-0.25%)
TSLA   510.50 (-0.58%)
AMD   50.93 (+2.33%)
T   38.38 (+0.92%)
ACB   2.13 (-0.93%)
F   9.16 (-0.11%)
NFLX   339.67 (+0.31%)
PRI   128.43 (+0.05%)
BAC   34.71 (-0.03%)
GILD   62.98 (-0.35%)
DIS   144.33 (-0.54%)
Log in

NASDAQ:NEPT - Neptune Wellness Solutions Stock Price, Forecast & News

$3.02
+0.13 (+4.50 %)
(As of 01/17/2020 04:00 PM ET)
Today's Range
$2.86
Now: $3.02
$3.09
50-Day Range
$2.49
MA: $2.73
$3.00
52-Week Range
$2.41
Now: $3.02
$6.57
Volume795,506 shs
Average Volume680,397 shs
Market Capitalization$284.61 million
P/E RatioN/A
Dividend YieldN/A
Beta1.7
Neptune Wellness Solutions Inc., a health and wellness products company, specializes in the extraction, purification and formulation of cannabis products, as well as other specialty ingredients, such as MaxSimil, a patented ingredient that enhances the absorption of lipid-based nutraceuticals, and various other marine and seed oils. Its custom formulations are available in various delivery forms, such as softgels, liquid solutions, nutritional emulsions, and chewables. Neptune Wellness Solutions Inc. was founded in 1998 and is headquartered in Laval, Canada.

Industry, Sector and Symbol

Industry Pharmaceutical preparations
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:NEPT
CUSIPN/A
Phone45-0687-2262

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$18.39 million
Book Value$0.66 per share

Profitability

Net Income$-17,670,000.00
Net Margins-187.60%

Miscellaneous

Employees58
Market Cap$284.61 million
Next Earnings Date2/12/2020 (Estimated)
OptionableOptionable

Receive NEPT News and Ratings via Email

Sign-up to receive the latest news and ratings for NEPT and its competitors with MarketBeat's FREE daily newsletter.


Neptune Wellness Solutions (NASDAQ:NEPT) Frequently Asked Questions

What is Neptune Wellness Solutions' stock symbol?

Neptune Wellness Solutions trades on the NASDAQ under the ticker symbol "NEPT."

How were Neptune Wellness Solutions' earnings last quarter?

Neptune Wellness Solutions Inc (NASDAQ:NEPT) issued its quarterly earnings data on Monday, November, 11th. The biotechnology company reported ($0.17) EPS for the quarter, missing analysts' consensus estimates of ($0.04) by $0.13. The biotechnology company had revenue of $4.93 million for the quarter, compared to analyst estimates of $6.42 million. Neptune Wellness Solutions had a negative return on equity of 39.61% and a negative net margin of 187.60%. View Neptune Wellness Solutions' Earnings History.

When is Neptune Wellness Solutions' next earnings date?

Neptune Wellness Solutions is scheduled to release their next quarterly earnings announcement on Wednesday, February 12th 2020. View Earnings Estimates for Neptune Wellness Solutions.

What is the consensus analysts' recommendation for Neptune Wellness Solutions?

2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Neptune Wellness Solutions in the last year. There are currently 2 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Neptune Wellness Solutions.

Has Neptune Wellness Solutions been receiving favorable news coverage?

Press coverage about NEPT stock has been trending very negative this week, InfoTrie Sentiment Analysis reports. InfoTrie ranks the sentiment of media coverage by reviewing more than six thousand news and blog sources in real-time. The firm ranks coverage of companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Neptune Wellness Solutions earned a media sentiment score of -3.6 on InfoTrie's scale. They also gave news stories about the biotechnology company a news buzz of 10.0 out of 10, indicating that recent media coverage is extremely likely to have an impact on the stock's share price in the next few days. View News Stories for Neptune Wellness Solutions.

Who are some of Neptune Wellness Solutions' key competitors?

What other stocks do shareholders of Neptune Wellness Solutions own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Neptune Wellness Solutions investors own include Canopy Growth (CGC), Aurora Cannabis (ACB), Cronos Group (CRON), Tilray (TLRY), Zynerba Pharmaceuticals (ZYNE), Aphria (APHA), Cara Therapeutics (CARA), New Age Beverages (NBEV), OrganiGram (OGI) and Innovative Industrial Properties (IIPR).

Who are Neptune Wellness Solutions' key executives?

Neptune Wellness Solutions' management team includes the folowing people:
  • Mr. James S. Hamilton, Pres, CEO & Director
  • Mr. Mario Paradis, VP & CFO
  • Mr. Marc Vaugeois, VP of Sales
  • Mr. Michel Timperio, Pres of Cannabis Bus.
  • Mr. François-Karl Brouillette, VP of Science & Innovation of Nutraceutical Bus.

How do I buy shares of Neptune Wellness Solutions?

Shares of NEPT can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is Neptune Wellness Solutions' stock price today?

One share of NEPT stock can currently be purchased for approximately $3.02.

How big of a company is Neptune Wellness Solutions?

Neptune Wellness Solutions has a market capitalization of $284.61 million and generates $18.39 million in revenue each year. The biotechnology company earns $-17,670,000.00 in net income (profit) each year or ($0.14) on an earnings per share basis. Neptune Wellness Solutions employs 58 workers across the globe.View Additional Information About Neptune Wellness Solutions.

What is Neptune Wellness Solutions' official website?

The official website for Neptune Wellness Solutions is http://www.neptunecorp.com/.

How can I contact Neptune Wellness Solutions?

Neptune Wellness Solutions' mailing address is 545 PROMENADE DU CENTROPOLIS SUITE 100, LAVAL A8, H7T 0A3. The biotechnology company can be reached via phone at 45-0687-2262 or via email at [email protected]


MarketBeat Community Rating for Neptune Wellness Solutions (NASDAQ NEPT)

Community Ranking:  2.6 out of 5 (star star)
Outperform Votes:  141 (Vote Outperform)
Underperform Votes:  126 (Vote Underperform)
Total Votes:  267
MarketBeat's community ratings are surveys of what our community members think about Neptune Wellness Solutions and other stocks. Vote "Outperform" if you believe NEPT will outperform the S&P 500 over the long term. Vote "Underperform" if you believe NEPT will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 1/17/2020 by MarketBeat.com Staff

Featured Article: Resistance Level

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel